During the past decade, Rheumatology Associates of Central Florida conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 20 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 12 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatology Associates of Central Florida" #1 sponsor was "Pfizer" with 10 trials, followed by "Human Genome Sciences Inc." with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Genelabs Technologies" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatology Associates of Central Florida" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Laboratory Corporation of America" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatology Associates of Central Florida" are "Rheumatoid Arthritis" (12 trials), "Arthritis, Rheumatoid" (4 trials), "Systemic Lupus Erythematosus" (4 trials), "Lupus Erythematosus, Systemic" (3 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "Rheumatology Associates of Central Florida" in a lesser frequency.

Most popular intervention types in "Rheumatology Associates of Central Florida" are "Drug" (30 trials), "Biological" (8 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Methotrexate" (4 trials), "Baricitinib" (3 trials), "Belimumab 1 mg/kg" (3 trials) and "Belimumab 10 mg/kg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatology Associates of Central Florida" are 34 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Rheumatology Associates of Central Florida". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Rheumatology Associates of Central Florida, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatology Associates of Central Florida, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".